Amazon Great Indian Festival 2020 - Electronics
Mutual Funds Commodities Research Tax Planning IPO Our Team Contact Us    
Google
Web www.equitybulls.com
Amazon Great Indian Festival 2020 - Electronics
Stock Report

| More

HCG - Strand Life Sciences Launch StrandAdvantage500 to Broaden Patient Access to Genomic Testing

Posted On: 2020-09-23 04:39:57


Envisioned to drive a new standard of cancer care, HealthCare Global Enterprises Limited (HCG Cancer Hospital Bengaluru) and Strand Life Sciences launched comprehensive genomic profiling (CGP), an approach to detect multiple actionable cancer biomarkers at 'one go' to optimize treatment for better clinical outcomes. HCG has joined hands with Strand to develop StrandAdvantage500, a simple and comprehensive Next Generation Sequencing (NGS) based assay that analyses cancer-relevant genetic alterations from DNA and RNA derived from a patient's tumor in one integrated workflow.

Speaking about the launch, Dr. B.S. Ajaikumar, Chairman and CEO, HCG Enterprises Ltd., said, "Cancer cases in India are on the rise, and the goal is to offer affordable as well as right cancer care. We have witnessed instances where patients do not respond to certain drugs due to their heterogeneous genetic makeup. Partnering with Strand and Illumina, we have been diligently profiling our patients to understand their genomic makeup and manage them accordingly. However, with CGP based tumor profiling, we will have consolidated cancer-relevant biomarker detection to understand more actionable genetic alterations upfront. With the launch of CGP using Strand Advantage500, HCG aims to implement an individualized predictive treatment model that will revolutionize cancer treatment by making it accessible for patients by offering substantial saving to the healthcare system. It will focus on improved outcomes, and ultimately follow the HCG way of treating cancer: the right way, the first time."

Dr Ramesh Hariharan, CEO, Strand Life Sciences, said, "As preferred partner of global diagnostic network, our goal is to be committed in helping the clinicians to make the right clinical decision for their patients. With cutting-edge Genomics and Bioinformatics expertise, strong multidisciplinary team and R&D capabilities, the launch of CGP using StrandAdvantage500 will immensely help to understand the heterogeneous disease like cancer."

Dr. Mithua Ghosh, Director and Head, Clinical Diagnostics, said, "Understanding the genetic profile of cancer helps oncologists penetrate the root cause of the disease at molecular and genetic level. StrandAdvantage500 enables simultaneous detection of multiple oncology biomarkers associated with approved and developing therapies across multiple cancer types and other genetic signatures such as tumor mutational burden (TMB) and microsatellite instability (MSI), which are the emerging biomarkers of immunotherapy. In a series of studies done in our laboratory, it was observed the up to 70-80% of patients had actionable genetic alterations identified by CGP. This information will enable the oncologists to use more targeted and immunotherapy for their patients and lead to more clinical trial enrollment."

Comprehensive genomic profiling with StrandAdvantage500 will overcome the challenge of iterative testing with limited biopsy samples and enable us to consolidate the detection of biomarkers into a single assay, thus saving precious biopsy samples, reducing the need of rebiopsy and provides faster and comprehensive results. This innovative approach will help in managing the disease better and design treatment with best possible clinical outcomes.

Shares of HealthCare Global Enterprises Ltd was last trading in BSE at Rs.121.1 as compared to the previous close of Rs. 119.8. The total number of shares traded during the day was 1754 in over 111 trades.

The stock hit an intraday high of Rs. 121.55 and intraday low of 119.35. The net turnover during the day was Rs. 212171.


Source: Equity Bulls

Click here to send ur comments or to feedback@equitybulls.com

Amazon Great Indian Festival 2020 - Mobiles





Other Headlines:

Maruti Suzuki teams with ORIX to launch 'Subscribe' for Hyderabad & Pune customers

JSPL produced rails for high-speed corridors approved by Indian Railways

Zydus Cadila receives Final Approval from USFDA for Solifenacin Succinate Tablets

Strides receives USFDA approval for Ethacrynic Acid Tablets

Steel Strips Wheels Ltd receives new orders for over $125K from US

Sumitomo Chemical India Ltd board to announce Q2FY21, H1FY21 results on Nov 5, 2020

SVP Global Ventures Ltd registered as approved Supplier with IKEA and other certifications

Sunteck Realty acquires approx. 50 acres in emerging micromarket, Vasind

Wipro awarded five-year Application Management and Service Integration & Management contract by Fortum

Dai-ichi Karkaria Limited receives further Rs. 12 crores from land sale

Reliance Retail receives subscription amount from TPG

Shares of Hexaware Technologies Ltd to stop trading from Nov 2, 2020

Shish Industries Ltd H1FY21 PAT at Rs. 0.51 crore

L&T Technology Services Ltd Board approves dividend of Rs. 7.50

Kiri Industries Ltd updates on appeal filed at Singapore Court of Appeal

Zensar divests its non-core TPM / MVS Business

L&T Technology Services Ltd posts Q2FY21 consolidated PAT of Rs. 165.5 crore

TATA Metaliks Ltd reports net profit of Rs. 82 crore in Q2FY21

ITC Ltd.'s Jelimals Immunoz' study reveals 94% children miss 'Going to school' and 95% miss 'Meeting friends' in person

Rallis India reports Q2 Consolidated Revenues at Rs. 725 Cr, PAT at Rs. 83 Crores

Texmaco Rail & Engineering Limited announces Financial Results for Q2 and HYl of FY 2020-21

CSB Bank - Q2FY21 - Surging Ahead

Bajrang Finance Ltd board approves voluntary delisting of Remi Edelstahl Tubulars Limited

Tata Tea Gold pays a sincere ode to the revered exuberance associated with Durga Puja and West Bengal's art and culture

Titan Biotech Ltd reports Rs. 7.58 crore consolidated PAT in Q2FY21

Sagarsoft India Ltd Q2FY21 net profit up at Rs. 1.42 crore

Britannia Industries Ltd Q2FY21 consolidated PAT slips QoQ to Rs. 498.13 crores

KIOCL Ltd board approves buyback at Rs. 110 per share

Key Highlights of Bank of Maharashtra's Q2FY21 results

Hero MotoCorp launches Splendor+ Black and Accent

TCS' New Workforce Analytics Solution to Help Companies Attract and Retain the Right Digital Talent

Jamna Auto Industries Trusts Ramco for Digital Transformation

Borosil Renewables Ltd Q2FY21 PAT at Rs. 14.05 crore

Wipro buyback - Arbitrage Opportunity - ICICI Securities

HDFC Life Insurance Company Ltd reports Rs. 327.83 crore consolidated PAT in Q2

ACC Ltd reports consolidated Q3CY2020 PAT of Rs. 363.84 crore

RALLIS India Ltd posts consolidated PAT of Rs. 82.95 crore in Q2FY21

Skipper Ltd posts consolidated PAT of Rs. 12.54 crore in Q2

Century Textiles & Industries Ltd Q2FY21 consolidated net loss at Rs. 14.13 crore

CSB Bank Ltd Q2FY21 net profit up at Rs. 68.90 crore

BALCO recognized in 'The Economic Times Best Brands 2020'

Hatsun Agro Product Limited board reviews CAPEX projects

JK Cement Ltd implements additional capacity of 3 Lac TPA of white cement

MCX launches futures trading on MCX METLDEX, India's first real-time Base Metal Index

Tata Chemicals Ltd board to announce Q2, H1 results on Oct 29, 2020

Hatsun Agro Product Limited board recommends 1:3 bonus issue

Hatsun Agro Product Ltd reports Q2FY21 net profit of Rs. 65.78 crore

Bank of Maharashtra Q2FY21 consolidated PAT at Rs. 130.44 crores

ITC Mangaldeep agarbatti brand performs 'Loka Kshema Puja' for the welfare & wellbeing of all

Smruthi Organics Ltd Q2FY21 PAT zooms to Rs. 5.83 crore







Website Created & Maintained by : Chennai Scripts
West Mambalam, Chennai - 600 033,
Tamil Nadu, India

disclaimer copyright © 2005 - 2019